Murine tissue staining

MM Michael MacLean
JJ Judyta Juranek
SC Swetha Cuddapah
RL Raquel López-Díez
HR Henry H. Ruiz
JH Jiyuan Hu
LF Laura Frye
HL Huilin Li
PG Paul F. Gugger
AS Ann Marie Schmidt
request Request a Protocol
ask Ask a question
Favorite

Mice were anesthetized with Ketamine and Xylazine and then underwent rapid cardiac perfusion with PBS, followed by 4% paraformaldehyde (PFA). The spinal column was rapidly removed, and the lumbar spinal cord was retrieved. Lumbar spinal cords were washed in PBS and then drop-fixed in 4% PFA for an additional 1 h at 4 °C. Gastrocnemius tissue was collected and drop-fixed 16 h in 1% PFA at 4 °C. After fixation, tissue was incubated with 15% sucrose in PBS for 24 h followed by incubation with 30% sucrose in PBS for an additional 24 h. Cyroprotected tissue was frozen in optimal cutting temperature (OCT) compound (FisherScientific, Cat: 23-730-571) and kept at − 80 °C until sectioning. Furthermore, 8-μm-thick serial sections were collected on Superfrost PLUS slides (FisherScientific, Cat: 22-037-246) using a Microm cryostat (ThermoFisher, Model: HM550). Sections were washed 3× with PBS for 5 min and then permeabilized with 0.2% Triton-X 100 in PBS for 10 min and washed 3× with PBS. Blocking was conducted with Serum-Free blocking buffer (Dako, Cat: X090930-2) for 1 h at RT. All primary antibodies were diluted in Antibody Diluent (Dako, Cat: S3022) and applied overnight at 4 °C. Subsequently, slides were washed 3× with PBS, then incubated with secondary antibodies diluted in Antibody Diluent for 1 h at RT. For slides containing DAPI, slides were washed and placed in a 1 μg/mL DAPI (Invitrogen, Cat: D1306) solution for 5 min at RT and washed 3× with PBS before mounting with fluorescent mounting media (Dako, Cat: S302380-2). Primary antibodies used: 1 μg/mL Mouse anti-RAGE (Millipore, Cat: MAB5328), 0.5 μg/mL Rat anti-CD11B (M1/70) (Invitrogen, Cat:14-0112-82), 0.25 μg/mL Rat anti-GFAP (2.2B10) (Invitrogen, Cat: 13-0300), 5 μg/mL Rat anti-CLEC7A (Invivogen, Cat: mabg-mdect), 1 μg/mL Mouse anti-AMIGO2 (G-7) (SantaCruz, Cat: sc-373699), 5 μg/mL Mouse anti-NeuN (Millipore, Cat: MAB377), 5 μg/mL Rat anti-CD68 (Abcam, Cat:ab53444), 5 μg/mL Rat anti-F4/80 (Abcam, Cat: ab6640), and 3 μg/mL Chicken anti-MAP2 (Abcam, Cat:ab5392). Secondary antibodies utilized: Donkey anti-Rat Alexa Fluor 488 (Invitrogen, Cat: A-21208), Donkey anti-Mouse Alexa Fluor 546 (Invitrogen, Cat: A10036), Donkey anti-Rat Alexa Fluor 594 (Invitrogen, Cat: A-21209), Donkey anti-Mouse Alexa Fluor 488 (Invitrogen, Cat: A21203), and Donkey anti-Chicken Alexa Fluor 647 (Jackson ImmunoResearch, Cat: 703-605-155). All secondary antibodies were used at 1 μg/mL. All experiments included negative controls by omission of primary antibody.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A